Joseph K. Belanoff. - 31 Dec 2024 Form 5 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Executive Officer, Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff.
Issuer symbol
CORT
Transactions as of
31 Dec 2024
Net transactions value
$0
Form type
5
Filing time
14 Feb 2025, 16:40:36 UTC
Previous filing
02 Aug 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Gift $0 -348,811 -65% $0.000000 190,417 06 Jul 2022 Direct
transaction CORT Common Stock Other $0 +348,811 +14% $0.000000 2,831,918 06 Jul 2022 Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 F1, F2, F3
transaction CORT Common Stock Gift $0 -190,417 -100% $0.000000 0 31 Jul 2024 Direct
transaction CORT Common Stock Other $0 +190,417 +6.7% $0.000000 3,022,335 31 Jul 2024 Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer of shares without consideration to the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02.
F2 Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
F3 Due to an administrative error, prior reporting of the name of this trust has been corrected. The exact name of the trust, "Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02" was mistakenly identified as the "Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02".